# About Glow Medicinal — GLOW Peptide Research Digest

> Glow Medicinal is an independent editorial publisher summarizing peer-reviewed research on the GLOW peptide blend — GHK-Cu, BPC-157, and TB-500. Not a clinic, not a vendor, not a prescription.

## What Glow Medicinal Is

Glow Medicinal is an independent editorial project that publishes summaries of the peer-reviewed research literature on the GLOW peptide blend — GHK-Cu, BPC-157, and TB-500. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The GLOW peptide blend combines three constituents studied in independent preclinical and clinical literatures spanning more than three decades. Our project is to make that literature legible: to index the mechanistic findings, note where evidence is strong, and be explicit about where it is absent.

The word 'medicinal' in our name is editorial framing — a position relative to a body of medical research literature, not a description of any service this site provides. We are not a medical service. We do not provide clinical consultation, diagnoses, or recommendations.

## Editorial Standards

Every quantitative claim on this site is cited to its published source. Our references are drawn from PubMed-indexed journals, PubMed Central, and ClinicalTrials.gov. We do not publish findings without citations and we do not invent citations.

Where constituent-level evidence exists, we report it with species, route, and dose context. Where blend-level evidence is absent — as it is for the GLOW combination — we say so explicitly. The blend caveat appears on the index, research, and benefits pages: no published controlled trial has examined GHK-Cu + BPC-157 + TB-500 as a single formulation. This is not a rhetorical disclaimer; it is the honest characterization of the literature as of the date of publication.

Regulatory status is reported factually: BPC-157 is an FDA Category 2 bulk drug substance (September 2023) and is prohibited by WADA under S0 (2022). TB-500 is prohibited by WADA under S2.3 (effective 2012). GHK-Cu is not currently listed on the WADA Prohibited List.

## What This Site Does Not Do

Glow Medicinal does not:

- Recommend doses, protocols, or administration schedules for any compound.
- Provide consultation, prescriptions, or clinical guidance.
- Sell, link to, or refer to any peptide vendor or supplier.
- Employ or refer to clinicians, pharmacists, or healthcare professionals.
- Claim any physical address, phone number, or clinic location.
- Imply that this site offers treatment, consultation, or prescription services.

The [GLOW peptide dosage](/dosage) page documents doses used in published research — these are study parameters, not recommendations. The [frequently asked questions](/faq) page answers questions directly from the published literature — not from clinical judgment.

---

An archival digest of the published constituent literature on the GLOW peptide blend — not a clinic, not a vendor, not a prescription.